APTA and VALD Spearhead Principal Data and Technology Collaboration to Advance Musculoskeletal Health Solutions and Improve Patient Outcomes

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ALEXANDRIA, Va., Jan. 23, 2025 /PRNewswire/ — The American Physical Therapy Association and VALD announce a new principal data and technology collaboration to advance digital musculoskeletal health solutions for physical therapy providers and their patients. Through a year-long collaboration, APTA and VALD are working together to leverage VALD’s advanced technology to enhance patient-centered outcomes and elevate the value of physical therapy care.

“APTA is proud to collaborate with VALD in advancing the digital health transformation that can benefit the physical therapy profession and improve health outcomes for the patients we serve,” said Drew Contreras, APTA vice president of strategic affairs. “As patient care becomes increasingly complex, it is essential to work alongside leading industry experts to ensure the physical therapy profession is positioned to be a solution for clinical care now and in the future.”

Laurie Malone, CEO of VALD, added, “Physical therapy is critically important to the health of the nation, and at VALD our mission has always been to support and augment that great work. We couldn’t think of a better way to do that than by partnering with APTA. Together we will advocate for PTs by putting data on their side, in turn demonstrating, enhancing, and promoting the profoundly positive impact of physical therapy.”

APTA has long committed to advancing and delivering cost-effective and accessible solutions in health care. Digital health solutions will not replace in-person care or the value of the physical therapist or physical therapist assistant, but the advancement of digital health technologies, used appropriately, will augment or enhance currently available care delivery models.

About APTA
The American Physical Therapy Association represents more than 100,000 physical therapists, physical therapist assistants, and physical therapy students nationwide. Visit apta.org to learn more.

About VALD
VALD is world leader in musculoskeletal assessment and rehabilitation technologies. Trusted by over 10,000 clinics, sporting teams, universities, hospitals, and defense departments around the world, VALD technologies are used by practitioners day in and day out to assess and monitor human movement, performance, and injury rehabilitation.

View original content to download multimedia:https://www.prnewswire.com/news-releases/apta-and-vald-spearhead-principal-data-and-technology-collaboration-to-advance-musculoskeletal-health-solutions-and-improve-patient-outcomes-302358900.html

SOURCE American Physical Therapy Association

Staff

Recent Posts

Phillips Medisize Launches TheraVolt Medical Connectors to Support Next-Gen Device Integration, Connectivity and Performance

Designed to address increasing demand for advanced medical connectors in growing specialties such as electrophysiology…

15 minutes ago

Phillips Medisize Launches TheraVolt Medical Connectors to Support Next-Gen Device Integration, Connectivity and Performance

Designed to address increasing demand for advanced medical connectors in growing specialties such as electrophysiology…

15 minutes ago

ForeSee Medical and Vim Announce Strategic Partnership to Enhance Risk Adjustment and Streamline Provider Workflows

SAN DIEGO--(BUSINESS WIRE)--ForeSee Medical Inc., a leading AI-powered risk adjustment software company, and Vim, a…

16 minutes ago

ForeSee Medical and Vim Announce Strategic Partnership to Enhance Risk Adjustment and Streamline Provider Workflows

SAN DIEGO--(BUSINESS WIRE)--ForeSee Medical Inc., a leading AI-powered risk adjustment software company, and Vim, a…

18 minutes ago

Butterfly Network’s RoHS Lead Exemption Revocation Request Progresses to Stakeholder and Consultant Assessment

Oeko-Institut appointed for third-party evaluation; stakeholder consultation will run June 6, 2025 - August 1,…

19 minutes ago

Ambio Life Sciences Launches World’s First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions

Facilities and care team tailored for patients with complex medical needs Specialized protocol includes optimized…

20 minutes ago